Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development (including related party expenses of $0) and $0 for the three months ended September 30, 2022 and 2021,respectively, and $0 and $2,359 for the nine months ended September 30, 2022 and 2021, respectively)	$ 47,679	$ 20,428	$ 117,825	$ 55,337
General and administrative	10,898	6,523	27,858	18,487
Total operating expenses	58,577	26,951	145,683	73,824
Loss from operations	(58,577)	(26,951)	(145,683)	(73,824)
Other income (expense), net:
Interest Expense	0	0	(2)	(7)
Interest income	1,190	90	1,723	245
Grant income	157	299	1,006	677
Realized gain on marketable securities	0	1	0	2
Foreign currency transaction gains	(687)	(54)	(2,479)	1,393
Total other income (expense), net	660	336	248	2,310
Net loss	$ (57,917)	$ (26,615)	$ (145,435)	$ (71,514)
Net loss per share, basic	$ (0.93)	$ (0.51)	$ (2.42)	$ (1.39)
Net loss per share, diluted	$ (0.93)	$ (0.51)	$ (2.42)	$ (1.39)
Weighted-average shares outstanding, basic	61,989,347	52,187,303	60,166,583	51,627,249
Weighted-average shares outstanding, diluted	61,989,347	52,187,303	60,166,583	51,627,249